Handelsbanken Fonder Ab Arrowhead Pharmaceuticals, Inc. Transaction History
Handelsbanken Fonder Ab
- $24.3 Billion
- Q1 2025
A detailed history of Handelsbanken Fonder Ab transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 41,200 shares of ARWR stock, worth $572,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,200
Previous 41,200
-0.0%
Holding current value
$572,268
Previous $775,000
32.26%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARWR
# of Institutions
299Shares Held
96.2MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$218 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$169 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$154 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$83.6 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$72.7 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.47B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...